---
accession : E-GEOD-17403
platform  : RNA-seq
pathway   : EGFR
cells     : HeLa
treatment : serum + EGF
effect    : activating
hours     : 24

control   :
    - GSM442016 1
    - GSM442017 1
    - GSM442018 1
treatment :
    - GSM442019 1
    - GSM442020 1
    - GSM442021 1
...
